Literature DB >> 16182184

Serum troponin I levels in hyperthyroid cats before and after treatment with radioactive iodine.

David J Connolly1, Javier Guitian, Adrian Boswood, Reto Neiger.   

Abstract

A raised concentration of serum cardiac troponin I (cTnI) is a sensitive marker of cardiac myocyte injury in the cat and assays developed for its measurement in human patients have been validated in the cat. Raised levels have been associated with a number of cardiac insults including hypertrophic cardiomyopathy and trauma. Hyperthyroidism is a common disease of older cats and excess thyroid hormone is known to produce significant cardiovascular effects in this species. This study evaluated the effect of treatment for hyperthyroidism with radioactive iodine on cTnI concentration, assessed the association between thyroxin levels and glomerular filtration rate (GFR) and cTnI concentration in cats treated for hyperthyroidism and described changes in echocardiographic parameters following treatment. Prior to the treatment serum cTnI was measured and echocardiography performed, thyroxin, cTnI, and echocardiography were then repeated at various time points following radioisotope therapy. The results show that higher thyroxin levels were significantly (P=0.002) associated with a higher likelihood of the cat presenting with detectable levels of cTnI. No significant association was found between GFR and presence of detectable levels of cTnI. Furthermore the results indicate that the effects of hyperthyroidism on echocardiographic parameters appear considerably less in this study than in previous studies and that the main outcome of treatment on these parameters is a significant reduction in fractional shortening (P=0.006). These results suggest that chronic exposure to excess thyroid hormone may induce myocyte damage of sufficient severity to raise serum cTnI concentration in a proportion of cats that resolves following establishment of a euthyroid state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182184     DOI: 10.1016/j.jfms.2005.01.002

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  6 in total

1.  Cardiac biomarkers in hyperthyroid cats.

Authors:  J K Sangster; D L Panciera; J A Abbott; K C Zimmerman; A C Lantis
Journal:  J Vet Intern Med       Date:  2013-12-18       Impact factor: 3.333

Review 2.  Cardiac Troponins in Dogs and Cats.

Authors:  R Langhorn; J L Willesen
Journal:  J Vet Intern Med       Date:  2015-12-17       Impact factor: 3.333

3.  Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease.

Authors:  Kieran Borgeat; Stijn J M Niessen; Lois Wilkie; Norelene Harrington; David B Church; Virginia Luis Fuentes; David J Connolly
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

4.  Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy.

Authors:  Yasutomo Hori; Masayuki Iguchi; Yasuhiro Heishima; Yohei Yamashita; Kensuke Nakamura; Atsushi Hirakawa; Akihito Kitade; Toshiki Ibaragi; Michio Katagi; Tamotsu Sawada; Masashi Yuki; Nobuyuki Kanno; Haruki Inaba; Noriko Isayama; Hideyuki Onodera; Naoki Iwasa; Mikio Kino; Mikihiro Narukawa; Syuhei Uchida
Journal:  J Vet Intern Med       Date:  2018-04-16       Impact factor: 3.333

5.  Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats.

Authors:  E S Bijsmans; R E Jepson; C Wheeler; H M Syme; J Elliott
Journal:  J Vet Intern Med       Date:  2017-04-07       Impact factor: 3.333

Review 6.  Updates on Laboratory Evaluation of Feline Cardiac Diseases.

Authors:  Alessandra Gavazza; Andrea Marchegiani; Lorenza Guerriero; Vanessa Turinelli; Andrea Spaterna; Sara Mangiaterra; Livio Galosi; Giacomo Rossi; Matteo Cerquetella
Journal:  Vet Sci       Date:  2021-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.